Arcutis Launches ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis
Arcutis Biotherapeutics(ARQT) GlobeNewswire News Room·2024-07-29 19:30Arcutis Biotherapeutics(ARQT) GlobeNewswire News Room·2024-07-29 19:30
R1Arcutis Biotherapeutics(ARQT) GlobeNewswire News Room·2024-07-29 19:30